Monopar Therapeutics Inc. <MNPR.O>: Barclays raises target price to $145 from $128
MNPR•Related News
Clearmind enrolls first AUD patients in CMND-100 clinical trial
CMND•
McDonald's <MCD.N>: TD Cowen cuts target price to $282 from $300
MCD•
Franklin Templeton sets September-November distributions for WIA, WIW closed-end funds
WIA•
Lighthouse Canton says AI compute boom shows no bubble as GPU rental rates climb 30% YTD
ORCL•
Wingstop Inc. <WING.O>: TD Cowen cuts target price to $120 from $160
WING•